148 related articles for article (PubMed ID: 37704773)
21. Effect of berberine on the renal tubular epithelial-to-mesenchymal transition by inhibition of the Notch/snail pathway in diabetic nephropathy model KKAy mice.
Yang G; Zhao Z; Zhang X; Wu A; Huang Y; Miao Y; Yang M
Drug Des Devel Ther; 2017; 11():1065-1079. PubMed ID: 28408805
[TBL] [Abstract][Full Text] [Related]
22. Berberine alleviates adipose tissue fibrosis by inducing AMP-activated kinase signaling in high-fat diet-induced obese mice.
Wang L; Ye X; Hua Y; Song Y
Biomed Pharmacother; 2018 Sep; 105():121-129. PubMed ID: 29852389
[TBL] [Abstract][Full Text] [Related]
23. Berberine Pretreatment Confers Cardioprotection Against Ischemia-Reperfusion Injury in a Rat Model of Type 2 Diabetes.
Chang W; Li K; Guan F; Yao F; Yu Y; Zhang M; Hatch GM; Chen L
J Cardiovasc Pharmacol Ther; 2016 Sep; 21(5):486-94. PubMed ID: 26846272
[TBL] [Abstract][Full Text] [Related]
24. Exploring the molecular mechanism of berberine for treating diabetic nephropathy based on network pharmacology.
Yang L; Yuan S; Wang R; Guo X; Xie Y; Wei W; Tang L
Int Immunopharmacol; 2024 Jan; 126():111237. PubMed ID: 37977063
[TBL] [Abstract][Full Text] [Related]
25. Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression.
Kong WJ; Zhang H; Song DQ; Xue R; Zhao W; Wei J; Wang YM; Shan N; Zhou ZX; Yang P; You XF; Li ZR; Si SY; Zhao LX; Pan HN; Jiang JD
Metabolism; 2009 Jan; 58(1):109-19. PubMed ID: 19059538
[TBL] [Abstract][Full Text] [Related]
26. Antihyperglycemia and Antihyperlipidemia Effect of Protoberberine Alkaloids From Rhizoma Coptidis in HepG2 Cell and Diabetic KK-Ay Mice.
Ma H; Hu Y; Zou Z; Feng M; Ye X; Li X
Drug Dev Res; 2016 Jun; 77(4):163-70. PubMed ID: 27045983
[TBL] [Abstract][Full Text] [Related]
27. Berberine Improves the Protective Effects of Metformin on Diabetic Nephropathy in db/db Mice through Trib1-dependent Inhibiting Inflammation.
Zhang B; Zhang X; Zhang C; Sun G; Sun X
Pharm Res; 2021 Nov; 38(11):1807-1820. PubMed ID: 34773184
[TBL] [Abstract][Full Text] [Related]
28. Identification and Verification of Potential Therapeutic Target Genes in Berberine-Treated Zucker Diabetic Fatty Rats through Bioinformatics Analysis.
Wu YS; Chen YT; Bao YT; Li ZM; Zhou XJ; He JN; Dai SJ; Li CY
PLoS One; 2016; 11(11):e0166378. PubMed ID: 27846294
[TBL] [Abstract][Full Text] [Related]
29. Berberine restored nitrergic and adrenergic function in mesenteric and iliac arteries from streptozotocin-induced diabetic rats.
Zhao L; Liu S; Wang M; Zhi M; Geng X; Hou C; Wang W; Zhao D
J Ethnopharmacol; 2019 Nov; 244():112140. PubMed ID: 31400506
[TBL] [Abstract][Full Text] [Related]
30. Berberine protects diabetic nephropathy by suppressing epithelial-to-mesenchymal transition involving the inactivation of the NLRP3 inflammasome.
Ma Z; Zhu L; Wang S; Guo X; Sun B; Wang Q; Chen L
Ren Fail; 2022 Dec; 44(1):923-932. PubMed ID: 35618411
[TBL] [Abstract][Full Text] [Related]
31. Sodium caprate augments the hypoglycemic effect of berberine via AMPK in inhibiting hepatic gluconeogenesis.
Zhang M; Lv X; Li J; Meng Z; Wang Q; Chang W; Li W; Chen L; Liu Y
Mol Cell Endocrinol; 2012 Nov; 363(1-2):122-30. PubMed ID: 22922125
[TBL] [Abstract][Full Text] [Related]
32. Swertisin rich fraction from Enicostema littorale ameliorates hyperglycemia and hyperlipidemia in high-fat fed diet and low dose streptozotacin induced type 2 diabetes mellitus in rats.
Mokashi P; Bhatt LK; Khanna A; Pandita N
Biomed Pharmacother; 2017 Dec; 96():1427-1437. PubMed ID: 29031588
[TBL] [Abstract][Full Text] [Related]
33. Berberine, a plant alkaloid with lipid- and glucose-lowering properties: From in vitro evidence to clinical studies.
Pirillo A; Catapano AL
Atherosclerosis; 2015 Dec; 243(2):449-61. PubMed ID: 26520899
[TBL] [Abstract][Full Text] [Related]
34. Berberine ameliorates diabetic nephropathy by inhibiting TLR4/NF-κB pathway.
Zhu L; Han J; Yuan R; Xue L; Pang W
Biol Res; 2018 Mar; 51(1):9. PubMed ID: 29604956
[TBL] [Abstract][Full Text] [Related]
35. Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease.
Zhao L; Cang Z; Sun H; Nie X; Wang N; Lu Y
BMC Endocr Disord; 2017 Feb; 17(1):13. PubMed ID: 28241817
[TBL] [Abstract][Full Text] [Related]
36. Berberine combined with stachyose induces better glycometabolism than berberine alone through modulating gut microbiota and fecal metabolomics in diabetic mice.
Li CN; Wang X; Lei L; Liu MZ; Li RC; Sun SJ; Liu SN; Huan Y; Zhou T; Liu Q; Cao H; Bai GL; Han YW; Shen ZF
Phytother Res; 2020 May; 34(5):1166-1174. PubMed ID: 31833107
[TBL] [Abstract][Full Text] [Related]
37. Dietary berberine can ameliorate glucose metabolism disorder of Megalobrama amblycephala exposed to a high-carbohydrate diet.
He C; Jia X; Zhang L; Gao F; Jiang W; Wen C; Chi C; Li X; Jiang G; Mi H; Liu W; Zhang D
Fish Physiol Biochem; 2021 Apr; 47(2):499-513. PubMed ID: 33501601
[TBL] [Abstract][Full Text] [Related]
38. Comparative effect of berberine and its derivative 8-cetylberberine on attenuating atherosclerosis in ApoE
Feng M; Zou Z; Zhou X; Hu Y; Ma H; Xiao Y; Li X; Ye X
Int Immunopharmacol; 2017 Feb; 43():195-202. PubMed ID: 28024280
[TBL] [Abstract][Full Text] [Related]
39. Berberine elevates mitochondrial membrane potential and decreases reactive oxygen species by inhibiting the Rho/ROCK pathway in rats with diabetic encephalopathy.
Tian L; Ri H; Qi J; Fu P
Mol Pain; 2021; 17():1744806921996101. PubMed ID: 33632015
[TBL] [Abstract][Full Text] [Related]
40. Berberine reduces ischemia/reperfusion-induced myocardial apoptosis via activating AMPK and PI3K-Akt signaling in diabetic rats.
Chen K; Li G; Geng F; Zhang Z; Li J; Yang M; Dong L; Gao F
Apoptosis; 2014 Jun; 19(6):946-57. PubMed ID: 24664781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
